Advancing Clinical Trials to Streamline Drug Development
Advancing Clinical Trials to Streamline Drug Development
The last decade in oncology has been marked by the identification of numerous new potential cancer targets and even more agents designed to inhibit them. The matrix of new targets, new agents, and the companion diagnostics required to identify the right patient for the right drug has created a major …